Your browser doesn't support javascript.
loading
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations.
Kan, Peter; Maragkos, Georgios A; Srivatsan, Aditya; Srinivasan, Visish; Johnson, Jeremiah; Burkhardt, Jan-Karl; Robinson, Timothy M; Salem, Mohamed M; Chen, Stephen; Riina, Howard A; Tanweer, Omar; Levy, Elad I; Spiotta, Alejandro M; Kasab, Sami Al; Lena, Jonathan; Gross, Bradley A; Cherian, Jacob; Cawley, C Michael; Howard, Brian M; Khalessi, Alexander A; Pandey, Aditya S; Ringer, Andrew J; Hanel, Ricardo; Ortiz, Rafael A; Langer, David; Kelly, Cory M; Jankowitz, Brian T; Ogilvy, Christopher S; Moore, Justin M; Levitt, Michael R; Binning, Mandy; Grandhi, Ramesh; Siddiq, Farhan; Thomas, Ajith J.
Afiliação
  • Kan P; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
  • Maragkos GA; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Srivatsan A; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
  • Srinivasan V; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
  • Johnson J; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
  • Burkhardt JK; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
  • Robinson TM; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Salem MM; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Chen S; Department of Radiology, Baylor College of Medicine, Houston, Texas.
  • Riina HA; Department of Neurosurgery, NYU Langone Medical Center, New York City, New York.
  • Tanweer O; Department of Neurosurgery, NYU Langone Medical Center, New York City, New York.
  • Levy EI; Department of Neurosurgery, University at Buffalo, State University of New York, Buffalo, New York.
  • Spiotta AM; Department of Neurosurgery, Medical College of South Carolina, Charleston, South Carolina.
  • Kasab SA; Department of Neurosurgery, Medical College of South Carolina, Charleston, South Carolina.
  • Lena J; Department of Neurosurgery, Medical College of South Carolina, Charleston, South Carolina.
  • Gross BA; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Cherian J; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
  • Cawley CM; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
  • Howard BM; Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia.
  • Khalessi AA; Department of Neurosurgery, University of California, San Diego, La Jolla, California.
  • Pandey AS; Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan.
  • Ringer AJ; Mayfield Clinic, TriHealth Neuroscience Institute, Good Samaritan Hospital, Cincinnati, Ohio.
  • Hanel R; Lyerly Neurosurgery, Baptist Neurological Institute, Jacksonville, Florida.
  • Ortiz RA; Department of Neurosurgery, Lenox Hill Hospital, New York City, New York.
  • Langer D; Department of Neurosurgery, Lenox Hill Hospital, New York City, New York.
  • Kelly CM; Department of Neurological Surgery, University of Washington, Seattle, Washington.
  • Jankowitz BT; Cooper Neuroscience Institute, Camden, New Jersey.
  • Ogilvy CS; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Moore JM; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Levitt MR; Department of Neurological Surgery, University of Washington, Seattle, Washington.
  • Binning M; Department of Neurosurgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Grandhi R; Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah.
  • Siddiq F; Department of Neurosurgery, University of Missouri, Columbia, Montana.
  • Thomas AJ; Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Neurosurgery ; 88(2): 268-277, 2021 01 13.
Article em En | MEDLINE | ID: mdl-33026434
ABSTRACT

BACKGROUND:

Middle meningeal artery (MMA) embolization has emerged as a promising treatment for chronic subdural hematoma (cSDH).

OBJECTIVE:

To determine the safety and efficacy of MMA embolization.

METHODS:

Consecutive patients who underwent MMA embolization for cSDH (primary treatment or recurrence after conventional surgery) at 15 centers were included. Clinical details and follow-up were collected prospectively. Primary clinical and radiographic outcomes were the proportion of patients requiring additional surgical treatment within 90 d after index treatment and proportion with > 50% cSDH thickness reduction on follow-up computed tomography imaging within 90 d. National Institute of Health Stroke Scale and modified Rankin Scale were also clinical outcomes.

RESULTS:

A total of 138 patients were included (mean age 69.8, 29% female). A total of 15 patients underwent bilateral interventions for 154 total embolizations (66.7% primary treatment). At presentation, 30.4% and 23.9% of patients were on antiplatelet and anticoagulation therapy, respectively. Median admission cSDH thickness was 14 mm. A total of 46.1% of embolizations were performed under general anesthesia, and 97.4% of procedures were successfully completed. A total of 70.2% of embolizations used particles, and 25.3% used liquid embolics with no significant outcome difference between embolization materials (P > .05). On last follow-up (mean 94.9 d), median cSDH thickness was 4 mm (71% median thickness reduction). A total of 70.8% of patients had >50% improvement on imaging (31.9% improved clinically), and 9 patients (6.5%) required further cSDH treatment. There were 16 complications with 9 (6.5%) because of continued hematoma expansion. Mortality rate was 4.4%, mostly unrelated to the index procedure but because of underlying comorbidities.

CONCLUSION:

MMA embolization may provide a safe and efficacious minimally invasive alternative to conventional surgical techniques.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hematoma Subdural Crônico / Embolização Terapêutica / Procedimentos Endovasculares / Artérias Meníngeas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hematoma Subdural Crônico / Embolização Terapêutica / Procedimentos Endovasculares / Artérias Meníngeas Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article